Clinical Trial Update: Liver Safety Under Upfront Arimidex vs Tamoxifen [Phase 4]

View source ↗

Summary

Phase 4 trial comparing upfront anastrozole (Arimidex) to tamoxifen in breast cancer provides results focused on liver safety. The results were posted in Januar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ARIMIDEX (anastrozole)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer | Phase 4 | Status: COMPLETED | Results posted: 2013-01-25